Black Swan Analysis is a provider of insightful commercialization ideas for the clients engaged in the healthcare sector.
The company delivers one-of-a-kind solutions, reliable epidemiology data, market and product overviews, and business opportunity evaluation for the clients who want to increase their capacity in producing and selling healthcare products.
Black Swan Analysis is an unrestricted resource of avant-garde solutions to the clients who want to upgrade their performance at the healthcare market. Our experience and ability to penetrate to the core of the problem enable us to produce exclusive market research reports that contain a variety of useful information including:
- Product profile
- SWOT analysis
- Growth drivers
- Market share
- Supply and demand channels
- Analysis of Competitors’ products and services
- New application areas
To ensure precise forecasting, we explore and analyze a vast variety of epidemiological and pathological data and study disease environment. Our clients can access disease epidemiology information and receive the accurate evaluation of the pricing policies of proprietors in the healthcare and pharmaceutical business.
We do not let our customers leave our company with half-baked information and weak decisions. Clients with unmet expectations are not about us. They appreciate Black Swan Analysis for adaptable solutions, proficiency, cost-effectiveness, and unique methodologies.
We help our pharmaceutical and healthcare partners recharge their capacities and increase their competitive rates. Our service algorithm is to work in close cooperation with the customer. Consistent inclusive communication helps us approach every commercial challenge expertly and invent unique business solutions.
Publications found:
186
Sort by:
Epiomic Epidemiology Series: Cystinosis Forecast in 19 Major Markets 2017-2027
US$ 5,800.00
Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Cystinosis in 19 Major Markets Cystinosis is a rare inherited lysosomal storage disorder caused by mutations ... 10-year forecast snapshot. This report is built using data and information sourced from the proprietary Epiomic patient segmentation ...
September 2017
58 pages
Epiomic Epidemiology Series: Graves’ Disease Forecast in 23 Major Markets 2017-2027
US$ 5,800.00
Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Graves’ Disease in 23 Major Markets Graves’ disease is an autoimmune disease of the thyroid gland, ... co-morbid conditions on Graves’ disease’s prevalent population. Identify sub-populations within Graves’ disease which require treatment. ...
September 2017
82 pages
Epiomic Epidemiology Series: Haemophilia Forecast in 17 Major Markets 2017-2027
US$ 5,800.00
Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Haemophilia in 17 Major Markets Haemophilia is a collective term describing rare, usually ... country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for haemophilia include: Development of inhibitors Haemophilic ...
September 2017
70 pages
Sickle Cell Disease Forecast in 10 Major Markets 2017-2027
US$ 6,150.00
... -populations within the main disease are also included at a country level across the 10-year forecast snapshot. These common Sickle cell disease co-morbidities include: Vaso ... on the impact from specific co-morbid conditions on sickle cell disease prevalent population. Identify sub-populations within sickle cell disease which require treatment. Gain an understanding of the ...
June 2017
44 pages
BRCA 1 & 2 Mutation in Cancer Forecast in 18 Major Markets 2017-2027
US$ 6,150.00
... in individuals that carry the mutations. This report provides the current prevalent population for BRCA1 & BRCA2 mutations in cancer populations across 18 Major ... for various countries. Provide a level of understanding on the impact of the mutation on the prevalent population for specific cancer types. Gain an understanding ...
May 2017
136 pages
Acute Respiratory Distress Syndrome (ARDS) Forecast in 11 Major Markets 2017-2027
US$ 6,150.00
Acute respiratory distress syndrome (ARDS) is an acute severe lung disease. It most often develops in those admitted to an intensive ... in protein-rich non-cardiogenic pulmonary oedema, refractory hypoxaemia and acute respiratory failure. This report provides the current prevalent population for ...
May 2017
42 pages
PD-L1 Overexpression in Solid Tumours Forecast in 18 Major Markets 2017-2027
US$ 6,150.00
PD-1 is a T-cell immune checkpoint that is involved in the dampening of autoimmunity in the peripheral effector phase of T-cell activation. This leads to a ‘tolerance’ of cells expressing PD-L1 (programmed death ligand-1). PD-L1 is expressed normally on a number of different cell types including; placenta, ...
May 2017
148 pages
Non-Alcoholic Fatty Liver Disease (NAFLD) Forecast in 11 Major Markets 2017-2027
US$ 6,150.00
Non-alcoholic fatty liver disease (NAFLD) is the presence of hepatic steatosis in the absence of competing liver disease. It is a spectrum of liver disorders associated with steatosis, with no evidence of significant alcohol consumption. NAFLD develops in four ... progress to cirrhosis, liver failure and, more rarely, hepatocellular carcinoma. This report provides the current prevalent population for Non-alcoholic fatty liver disease (NAFLD) across 11 Major ...
April 2017
50 pages
Myasthemia Gravis Forecast in 26 Major Markets 2017-2027
US$ 6,150.00
... are also included at a country level across the 10-year forecast snapshot. MG often co-occurs with other autoimmune conditions including: RA MS ... from specific co-morbid conditions on Myasthenia Gravis prevalent population. Identify sub-populations within Myasthenia Gravis which require treatment. Gain an ...
March 2017
92 pages
Diabetic Gastroparesis Forecast in 12 Major Markets 2017-2027
US$ 6,150.00
... also included at a country level across the 10-year forecast snapshot. These gastrointestinal symptoms include: Nausea ... impact from specific co-morbid conditions on Diabetic Gastroparesis prevalent population. Identify sub-populations within Diabetic Gastroparesis which require treatment. Gain an understanding ...
March 2017
50 pages
Colorectal Cancer Forecast in 18 Major Markets 2017-2027
US$ 6,150.00
... included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Colorectal Cancer include: Change in bowel habits, including diarrhoea ... on the impact from specific co-morbid conditions on Colorectal Cancer incident population. Identify sub-populations within Colorectal Cancer which require treatment. Gain an understanding of the ...
February 2017
90 pages
Erectile Dysfunction Forecast in 29 Major Markets 2017-2027
US$ 6,150.00
... included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Erectile Dysfunction disease include: Chronic heart disease Hypertension ... on the impact from specific co-morbid conditions on Erectile Dysfunction prevalent population. Identify sub-populations within Erectile Dysfunction which require treatment. Gain an understanding of the ...
February 2017
62 pages
Ankylosing Spondylitis Forecast in 13 Major Markets 2017-2027
US$ 6,150.00
... at a country level across the 10-year forecast snapshot. There are several features associated with Ankylosing Spondylitis, these include: Psoriasis Uveitis IBD Enthesitis ... on the impact from specific co-morbid conditions on Ankylosing Spondylitis prevalent population. Identify sub-populations within Ankylosing Spondylitis which require treatment. Gain an understanding of the ...
February 2017
70 pages
Dyslipidaemia Forecast in 12 Major Markets 2017-2027
US$ 6,150.00
... of dyslipidaemia on more than one factor. This report provides the current prevalent population for Dyslipidaemia across 12 Major Markets (USA ... are also included at a country level across the 10-year forecast snapshot. Dyslipidaemia is associated with increased risk of cardiovascular events including ...
February 2017
58 pages
Oesophageal Cancer Forecast in 18 Major Markets 2017-2027
US$ 6,150.00
... tumours of the oesophagus are responsible for the majority of oesophageal cancers. The majority of oesophageal cancers can be subdivided into two main histological subtypes: Adenocarcinomas ... level across the 10-year forecast snapshot. There are several features associated with the development and progression of oesophageal cancer, these include: Fistula ...
February 2017
70 pages
Type 1 Diabetes Mellitus Forecast in 12 Major Markets 2017-2027
US$ 6,150.00
... at a country level across the 10-year forecast snapshot. There are many co-morbidities associated with Type 1 Diabetes Mellitus, including: Chronic pancreatitis Cystic fibrosis Autoimmune ... on the impact from specific co-morbid conditions on Type 1 Diabetes Mellitus prevalent population. Identify sub-populations within Type 1 Diabetes Mellitus which require treatment. Gain an understanding of the ...
February 2017
54 pages
Epiomic Epidemiology Series: Bell's Palsy Forecast in 15 Major Markets 2017-2027
US$ 6,150.00
... information sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources used ... co-morbid conditions on Bell’s palsy incident population. Identify sub-populations within Bell’s palsy which require treatment. ...
January 2017
62 pages
Epiomic Epidemiology Series: Non-Hodgkin Lymphoma Forecast in 18 Major Markets 2017-2027
US$ 6,150.00
... sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Non-Hodgkin Lymphoma incident population. Identify sub-populations within Non-Hodgkin Lymphoma which require treatment ...
January 2017
92 pages
Alzheimer's Disease Forecast in 12 Major Markets 2017-2027
US$ 6,150.00
... the main disease are also included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Alzheimer’s disease include: Other ... on the impact from specific co-morbid conditions on Alzheimer’s disease’s prevalent population. Identify sub-populations within Alzheimer’s disease which require treatment. Gain an understanding of the ...
January 2017
56 pages
Irritable Bowel Syndrome Forecast in 12 Major Markets 2017-2027
US$ 6,150.00
... included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Irritable Bowel Syndrome include: Abdominal pain Abdominal cramping Bloated ... on the impact from specific co-morbid conditions on Irritable Bowel Syndrome prevalent population. Identify sub-populations within Irritable Bowel Syndrome which require treatment. Gain an understanding of the ...
January 2017
48 pages
Lewy Body Dementia Forecast in 12 Major Markets 2017-2027
US$ 6,150.00
... included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Lewy Body Dementia disease include: Problems with alertness and ... on the impact from specific co-morbid conditions on Lewy Body Dementia prevalent population. Identify sub-populations within Lewy Body Dementia which require treatment. Gain an understanding of the ...
January 2017
48 pages
Liver Cancer Forecast in 18 Major Markets 2017-2027
US$ 6,150.00
Liver Cancer, also known as hepatic cancer or primary liver cancer, is a cancer which starts in the cells of the liver. The most common form is hepatocellular carcinoma (HCC) which originates ... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Liver Cancer include: Type 2 Diabetes Mellitus Liver Cirrhosis Hepatitis C Hepatitis B This ...
January 2017
64 pages
Osteopenia & Osteoporosis Forecast in 13 Major Markets 2017-2027
US$ 6,150.00
... are also included at a country level across the 10-year forecast snapshot. The following conditions and comorbidities are ... from specific co-morbid conditions on Osteopenia and Osteoporosis prevalent population. Identify sub-populations within Osteopenia and Osteoporosis which require treatment. Gain an ...
January 2017
84 pages
Hearing Loss Forecast in 12 Major Markets 2017-2027
US$ 6,150.00
... to the brain (neural loss). It should be noted that hearing loss can be temporary in some instances, such as conductive hearing loss due to infection. Hearing loss can occur in one (bilateral ... included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Hearing Loss include: Vertigo Tinnitus Hyperacusis Depression This ...
January 2017
48 pages
Epiomic Epidemiology Series: Chronic Hepatitis C Forecast in 12 Major Markets 2017-2027
US$ 6,150.00
... forecast snapshot. Chronic hepatitis C is most often associated with co-infections with other chronic viral ... information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... from patient registries, clinical trials and epidemiology studies. All of the sources used ...
December 2016
60 pages
Epiomic Epidemiology Series: Muscular Dystrophies Forecast in 12 Major Markets 2017-2027
US$ 6,150.00
... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Muscular Dystrophies prevalent population. Identify sub-populations within Muscular Dystrophies which require treatment ...
December 2016
44 pages
Epiomic Epidemiology Series: Vascular Dementia Forecast in 13 Major Markets 2017-2027
US$ 6,150.00
... by a series of minor strokes. This report provides the current prevalent population for Vascular Dementia ... Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database ... from patient registries, clinical trials and epidemiology studies. All of the sources used ...
December 2016
50 pages
Epiomic Epidemiology Series: Multiple Sclerosis Forecast in 18 Major Markets 2017-2027
US$ 6,150.00
... is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and ...
December 2016
98 pages
Epiomic Epidemiology Series: Leukaemia Forecast in 18 Major Markets 2017-2027
US$ 6,150.00
... at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used to ...
December 2016
82 pages
Epiomic Epidemiology Series: Cholera Forecast for selected Asian Markets 2017-2027
US$ 2,900.00
... cholerae species (O1, O139), usually spread through contaminated water. Cholera causes severe diarrhoea and dehydration. Left untreated, cholera ... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ...
December 2016
38 pages
Epiomic Epidemiology Series: Norovirus Forecast for selected Asian Markets 2017-2027
US$ 2,900.00
... of norovirus outbreaks. This report provides the current incident population for Norovirus across ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information form patient registries, clinical trials and epidemiology studies. All of the sources used to ...
December 2016
40 pages
Epiomic Epidemiology Series: Adult Obstructive Sleep Apnoea Forecast in 8 Major Markets 2016-2026
US$ 6,150.00
Summary Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Adult Obstructive Sleep Apnoea in 8 Major Markets Adult obstructive sleep apnoea, otherwise known as Obstructive Sleep Apnea-Hypopnea (OSAH ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and ...
November 2016
44 pages
Epiomic Epidemiology Series: Acne Vulgaris Forecast in 15 Major Markets 2016-2026
US$ 6,150.00
Summary Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Acne Vulgaris in 15 Major Markets Acne, or Acne Vulgaris (AV), is a chronic inflammatory disease of the pilosebaceous unit. Although acne can develop at any ... on the impact from specific co-morbid conditions on Acne Vulgaris’s prevalent population. Identify sub-populations within Acne Vulgaris which require treatment. Gain an understanding of the ...
November 2016
72 pages
Epiomic Epidemiology Series: Polycythemia Vera Forecast in 27 Major Markets 2016-2026
US$ 6,150.00
Polycythemia Vera (PV), also known as erythraemia, erythrocytosis, erythrocytosis megalosplenica, Osler disease, primary polycythemia, polycythemia rubra vera ... sourced from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the sources ...
November 2016
102 pages
Epiomic Epidemiology Series: Fragile X Syndrome Forecast in 11 Major Markets 2016-2026
US$ 6,150.00
... with Fragile X Syndrome include: Autistic-like features Fragile X tremor ataxia syndrome (FXTAS) Fragile X ... information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used ...
October 2016
44 pages
Epiomic Epidemiology Series: Hypertension Forecast in 12 Major Markets 2016-2026
US$ 6,150.00
... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Hypertension include: ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used ...
October 2016
56 pages
Epiomic Epidemiology Series: Prostate Cancer Forecast in 18 Major Markets 2016-2026
US$ 6,150.00
... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Prostate Cancer’s incident population. Identify sub-populations within Prostate Cancer which require treatment ...
September 2016
42 pages